# Phase III Study Evaluating Induction Chemotherapy Followed by Chemoradiotherapy Compared to Standard Chemoradiotherapy for Locally Advanced SCCA

> **NCT06207981** · PHASE3 · RECRUITING · sponsor: **Federation Francophone de Cancerologie Digestive** · enrollment: 310 (estimated)

## Conditions studied

- Anal Cancer

## Interventions

- **DRUG:** induction chemotherapy (mDCF)
- **DRUG:** Concomitant chemotherapy (Capecitabin + Mitomycin-C)
- **RADIATION:** radiotherapy

## Key facts

- **NCT ID:** NCT06207981
- **Lead sponsor:** Federation Francophone de Cancerologie Digestive
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-02-26
- **Primary completion:** 2029-02-01
- **Final completion:** 2030-02-01
- **Target enrollment:** 310 (ESTIMATED)
- **Last updated:** 2025-09-02

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06207981

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06207981, "Phase III Study Evaluating Induction Chemotherapy Followed by Chemoradiotherapy Compared to Standard Chemoradiotherapy for Locally Advanced SCCA". Retrieved via AI Analytics 2026-07-27 from https://api.ai-analytics.org/clinical/NCT06207981. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*